Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Not applicable Interventional Results available

ExCEED: CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis

ClinicalTrials.gov ID: NCT03517436

Public ClinicalTrials.gov record NCT03517436. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 1:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Single-arm, Controlled, Multicenter Study to Establish the Safety and Effectiveness of the CENTERA THV System in Intermediate Risk Patients Who Have Symptomatic, Severe, Calcific, Aortic Stenosis Requiring Aortic Valve Replacement

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will monitor the safety and valve performance of the Edwards CENTERA Transcatheter Heart Valve (THV) System in patients with symptomatic, severe, calcific aortic stenosis who are at intermediate operative risk for surgical aortic valve replacement (SAVR).

Study identification

NCT ID
NCT03517436
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Not applicable
Lead sponsor
Edwards Lifesciences
Industry
Enrollment
101 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 18, 2018 (Actual)
Primary completion
Oct 2, 2020 (Actual)
Completion
Jul 2030 (Estimated)
Last update posted
Nov 13, 2025

2018 – 2030

United States locations

U.S. sites
23
U.S. states
16
U.S. cities
22
Facility City State ZIP Site status
Cedars-Sinai Medical Center Los Angeles California 90048 —
Stanford University Medical Center Stanford California 94305 —
UC Health Northern Colorado (Medical Center of the Rockies) Loveland Colorado 80538 —
Washington Hospital Center Washington D.C. District of Columbia 20010 —
Sarasota Memorial Hospital Sarasota Florida 34239 —
Emory University Atlanta Georgia 30308 —
St. Vincent Medical Group, Inc./St. Vincent Heart Center of Indiana, LLC Indianapolis Indiana 46290 —
University of Kansas Health System Kansas City Kansas 66160 —
Cardiovascular Research Institute of Kansas Wichita Kansas 67226 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Henry Ford Hospital Detroit Michigan 48202 —
Washington University/ Barnes-Jewish Hospital St Louis Missouri 63110 —
Atlantic Health System Hospital Corp Morristown New Jersey 07960 —
Columbia University Medical Center/ NYPH New York New York 10032 —
The Ohio Health Research Institute Columbus Ohio 43214 —
University of Pennsylvania Philadelphia Pennsylvania 19104 —
Allegheny - Singer Research Institute Pittsburgh Pennsylvania 15212 —
Saint Thomas Health Nashville Tennessee 37205 —
Baylor Heart and Vascular Hospital Dallas Texas 75226 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
University of Texas Memorial Hermann Houston Texas 77030 —
The Heart Hospital Baylor Plano Plano Texas 75093 —
Baylor Scott and White, Central Texas Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03517436, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2025 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03517436 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →